Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma
Authors
Keywords
Renal cell carcinoma, SLC6A3, Expression profiling, Biomarker, Microarray, Sertraline
Journal
Molecular Cancer
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-02-02
DOI
10.1186/s12943-016-0495-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of novel long non-coding RNAs in clear cell renal cell carcinoma
- (2015) Jasmine Blondeau et al. Clinical Epigenetics
- Neuronal Pentraxin 2 Supports Clear Cell Renal Cell Carcinoma by Activating the AMPA-Selective Glutamate Receptor-4
- (2014) Christina A. von Roemeling et al. CANCER RESEARCH
- Continued Increase in Incidence of Renal Cell Carcinoma, Especially in Young Patients and High Grade Disease: United States 2001 to 2010
- (2014) Sallyann Coleman King et al. JOURNAL OF UROLOGY
- Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
- (2014) Marco Gerlinger et al. NATURE GENETICS
- Microarray-based detection and expression analysis of ABC and SLC transporters in drug-resistant ovarian cancer cell lines
- (2013) Radosław Januchowski et al. BIOMEDICINE & PHARMACOTHERAPY
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
- (2013) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Integrated molecular analysis of clear-cell renal cell carcinoma
- (2013) Yusuke Sato et al. NATURE GENETICS
- The Reactome pathway knowledgebase
- (2013) David Croft et al. NUCLEIC ACIDS RESEARCH
- Refining the Use of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma
- (2013) Jeffrey La Rochelle et al. SEMINARS IN ONCOLOGY
- Sertraline, an Antidepressant, Induces Apoptosis in Hepatic Cells Through the Mitogen-Activated Protein Kinase Pathway
- (2013) Si Chen et al. TOXICOLOGICAL SCIENCES
- Neuronal pentraxin II (NPTX2) Is Frequently Down-Regulated by Promoter Hypermethylation in Pancreatic Cancers
- (2012) Ling Zhang et al. DIGESTIVE DISEASES AND SCIENCES
- BAP1 loss defines a new class of renal cell carcinoma
- (2012) Samuel Peña-Llopis et al. NATURE GENETICS
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- An Antioxidant Response Phenotype Shared between Hereditary and Sporadic Type 2 Papillary Renal Cell Carcinoma
- (2011) Aikseng Ooi et al. CANCER CELL
- Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma
- (2010) Huiqing Liu et al. BMC Systems Biology
- Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma
- (2010) Jörg Ellinger et al. INTERNATIONAL JOURNAL OF CANCER
- Ontology-Based Meta-Analysis of Global Collections of High-Throughput Public Data
- (2010) Ilya Kupershmidt et al. PLoS One
- Regulation of endocytosis via the oxygen-sensing pathway
- (2009) Yi Wang et al. NATURE MEDICINE
- Correlation of mRNA and protein levels: Cell type-specific gene expression of cluster designation antigens in the prostate
- (2008) Laura E Pascal et al. BMC GENOMICS
- SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder
- (2008) Johanna Krause Expert Review of Neurotherapeutics
- The kallikrein–kinin system in diabetic retinopathy: Lessons for the kidney
- (2008) J.A. Phipps et al. KIDNEY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now